Clearpoint Neuro Inc (CLPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 8,861 | 9,215 | 8,485 | 7,771 | 8,122 |
| Cost of Goods | 3,261 | 3,659 | 3,353 | 3,009 | 3,275 |
| Gross Profit | 5,600 | 5,556 | 5,132 | 4,762 | 4,847 |
| Operating Expenses | 11,137 | 11,895 | 11,648 | 10,419 | 10,280 |
| Operating Income | -5,276 | -5,680 | -6,163 | -5,648 | -5,158 |
| Other Income | -607 | -132 | 155 | 218 | 198 |
| Pre-tax Income | -5,883 | -5,812 | -6,008 | -5,430 | -4,960 |
| Income Tax | 8 | 25 | 18 | N/A | 14 |
| Net Income Continuous | -5,891 | -5,837 | -6,026 | -5,386 | -4,974 |
| Net Income | $-5,891 | $-5,837 | $-6,026 | $-5,386 | $-4,974 |
| EPS Basic Total Ops | -0.21 | -0.21 | -0.22 | -0.20 | -0.18 |
| EPS Basic Continuous Ops | -0.21 | -0.21 | -0.22 | -0.20 | -0.18 |
| EPS Diluted Total Ops | -0.21 | -0.21 | -0.22 | -0.20 | -0.18 |
| EPS Diluted Continuous Ops | -0.21 | -0.21 | -0.22 | -0.20 | -0.18 |
| EPS Diluted Before Non-Recurring Items | -0.21 | -0.21 | -0.22 | -0.20 | -0.18 |
| EBITDA(a) | $-4,811 | $-5,033 | $-5,829 | $-5,177 | $-4,641 |